Pharma Social Media Sites Struggle For Audience Under Shadow Of Potential FDA Action

Drug makers are using YouTube videos and other social media channels to broadcast their expertise and initiatives; Amgen differentiates its biologic manufacturing from biosimilars, J&J teams up with Huffington Post to tell stories about motherhood, and Pfizer tries to conduct a clinical trial online.

If Golden Globes and Oscars were handed out for social media campaigns they would get a lot more attention. That’s certainly true for the Twitter feeds, Facebook pages and YouTube videos being churned out in the pharmaceutical industry.

While most drug companies produce such offerings, relatively few people tap into them. But there are some entertaining and newsworthy nuggets buried on pharma social media sites. Take, for example, Amgen Inc.’s video on manufacturing a biologic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America